Your browser doesn't support javascript.
loading
Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells.
Casado, Pedro; Wilkes, Edmund H; Miraki-Moud, Farideh; Hadi, Marym Mohammad; Rio-Machin, Ana; Rajeeve, Vinothini; Pike, Rebecca; Iqbal, Sameena; Marfa, Santiago; Lea, Nicholas; Best, Steven; Gribben, John; Fitzgibbon, Jude; Cutillas, Pedro R.
Afiliação
  • Casado P; Cell Signalling & Proteomics Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Wilkes EH; Cell Signalling & Proteomics Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Miraki-Moud F; Cancer Immunology Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Hadi MM; Cell Signalling & Proteomics Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Rio-Machin A; Precision Medicine Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Rajeeve V; Cell Signalling & Proteomics Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Pike R; Flow Cytometry Core Facility, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Iqbal S; Tissue Bank, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Marfa S; Cell Signalling & Proteomics Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Lea N; Department of Haematological Medicine, King's College London School of Medicine, London, UK.
  • Best S; Department of Haematological Medicine, King's College London School of Medicine, London, UK.
  • Gribben J; Cancer Immunology Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Fitzgibbon J; Precision Medicine Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Cutillas PR; Cell Signalling & Proteomics Group, Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK. p.cutillas@qmul.ac.uk.
Leukemia ; 32(8): 1818-1822, 2018 08.
Article em En | MEDLINE | ID: mdl-29626197
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Leucemia Mieloide Aguda / Biomarcadores Tumorais / Diferenciação Celular / Proteoma / Inibidores de Proteínas Quinases / Transcriptoma Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Leucemia Mieloide Aguda / Biomarcadores Tumorais / Diferenciação Celular / Proteoma / Inibidores de Proteínas Quinases / Transcriptoma Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article